GDNF in treatment of Parkinson's disease: response to editorial.
Penn
Richard D
RD
Dalvi
Arif
A
Slevin
John
J
Young
Byron
B
Gash
Don
D
Gerhardt
Greg
G
Hutchinson
Michael
M
D002986:Clinical Trials as Topic; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D028701:Patient Rights
D051100:Glial Cell Line-Derived Neurotrophic Factor